-
Loading metrics
Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis
- Qiying Chen,
- Tianyu Chen,
- Weicheng Lin,
- Xi Chen
x
- Published: June 10, 2026
- https://doi.org/10.1371/journal.pone.0351059
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics